Enhance MD vs Sprout Health: Pricing, Speed, and Compounds
Choosing between Enhance MD and Sprout Health comes down to three clear trade offs: introductory price and multi-compound access, ongoing pricing structure, and onboarding speed with outcome framing. Early verdict: Enhance MD is the lower-cost, multi-compound option for price-conscious patients; Sprout Health is aimed at people who want the fastest approval and a clear outcome message.
Start with Enhance MD pricing from $49
Side-by-side snapshot: core differences
| Criterion | Enhance MD | Sprout Health |
|---|---|---|
| Introductory price | Semaglutide from $49; tirzepatide from $99 first month | $50 off first month, bringing it to $199 |
| Ongoing price model | Flat-rate pricing: same price at every dose after intro | $249/month ongoing after discount |
| Compound options | Both semaglutide and tirzepatide available on one platform | Compounded semaglutide only per captured evidence |
| Onboarding speed and outcomes | Standard clinician review process; clinician-directed care | Lightning-quick approval and 10–26% weight loss framing over 12 months |
| Regulatory note | Compounded medications are not FDA-approved for safety, effectiveness or quality | Compounded medications are not FDA-approved; medication-specific status must be confirmed |
Pricing and cost predictability compared
Enhance MD emphasizes low first-month entry pricing and consistent billing during titration. Evidence shows semaglutide from $49 and tirzepatide from $99 for the first month, and a stated flat-rate policy so the price stays the same at every dose once ongoing rates apply. Sprout Health highlights a $50 first-month discount that brings the initial month to $199 and documents a $249/month ongoing rate. If you need exact ongoing numbers for Enhance MD, the captured content notes flat-rate billing but ongoing rates are not always prominently published before intake.
See Enhance MD flat-rate details
Compound availability and treatment options
Enhance MD explicitly offers both compounded semaglutide and compounded tirzepatide on a single platform, which the source frames as useful for patients deciding between compounds. Sprout Health’s captured evidence emphasizes compounded semaglutide and does not show tirzepatide availability in the supplied material. Both providers note that compounded medications are not FDA-approved and that treatment is available only when a licensed clinician determines it is medically appropriate.
Onboarding speed, outcomes, and patient experience
Sprout Health positions itself around a fast, low-friction onboarding with “lightning-quick approval” and outcome framing that cites 10 to 26 percent body weight reduction over 12 months. Enhance MD focuses messaging on clinician-directed care and has treated more than 10,000 patients per the captured copy, but the evidence does not claim the same rapid approval language or the specific outcome range shown by Sprout Health.
Get Sprout Health fast approval
Regulatory and program notes to know
Both providers use compounded medications in the captured material and include regulatory qualifiers: compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Both platforms require a licensed clinician to determine medical appropriateness. Sprout Health materials also advise confirming medication-specific approval status.
Which differences matter most?
The most distinctive supported differences are: 1) introductory price and multi-compound choice with Enhance MD offering semaglutide from $49 and tirzepatide from $99, 2) ongoing pricing model where Enhance MD emphasizes flat-rate pricing and Sprout Health documents $249/month after the discount, and 3) onboarding speed and outcome framing where Sprout Health claims lightning-quick approval and a 10–26 percent weight loss framing over 12 months.
Explore Sprout Health offer and outcomes
Conclusion: Enhance MD vs Sprout Health
Enhance MD vs Sprout Health splits into a lower-cost, multi-compound entry versus a faster onboarding experience with outcome-focused marketing. Enhance MD is clear about semaglutide from $49 and tirzepatide from $99 first-month pricing and flat-rate dosing thereafter. Sprout Health offers $50 off the first month to $199 and a $249/month ongoing price with fast approval and a 10–26 percent outcome framing.
Choose Enhance MD if you want the lowest first-month pricing and access to both semaglutide and tirzepatide on one platform with flat-rate dosing. Choose Sprout Health if you prioritize lightning-quick approval and explicit outcome framing over the lowest ongoing cost.
Primary keyword: Enhance MD vs Sprout Health